VB0.F Viva Biotech Holdings

Healthcare Biotechnology Frankfurt Exchange
0.1440 EUR
Close of Nov 12, 2026
0.1160 0.2900
Market cap
EUR 301M
P/E
14.4x
P/B
0.58x
ROE
5.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is VB0.F undervalued?

Graham number
Price0.1440
Graham value0.2368
Discount39.2%

VB0.F trades 39.2% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Viva Biotech Holdings fundamental analysis

No fundamental analysis for Viva Biotech Holdings yet.

Viva Biotech Holdings stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Viva Biotech Holdings

Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, including protein expression, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacology and DMPK; chemistry services, such as medicinal and synthetic chemistry, purification preparation, and computer-aided drug design ser…

Full company profile